More about High-Yield Cash Accounts with M1
Brokerage Accounts
Retirement Accounts
Other Accounts
Quotes are delayed by 15 minutes.
1D
1W
1M
3M
6M
YTD
1Y
2Y
5Y
ALL
Market cap
$300483523
EPS
1.18
P/E ratio
21.7
Price to sales
2.97
Dividend yield
--
Beta
0.531012
Previous close
$37.08
Today's open
$36.60
Day's range
$36 - $37.49
52 week range
$17.73 - $40
show more
CEO
James L. Cunniff
Employees
180
Headquarters
New Prague, MN
Exchange
NYSE American
Shares outstanding
8280064
Issue type
Common Stock
Healthcare
Medical Equipment & Supplies
Is Electromed (ELMD) a Solid Growth Stock? 3 Reasons to Think "Yes"
Electromed (ELMD) is well positioned to outperform the market, as it exhibits above-average growth in financials.
Zacks Investment Research • Jun 3, 2026

New Strong Buy Stocks for June 2nd
GOLD, ELMD, TPR, PLGO and CRGY have been added to the Zacks Rank #1 (Strong Buy) List on June 2nd, 2026.
Zacks Investment Research • Jun 2, 2026

Best Momentum Stocks to Buy for June 2nd
GOLD, ELMD and TPR made it to the Zacks Rank #1 (Strong Buy) momentum stocks list on June 2nd, 2026.
Zacks Investment Research • Jun 2, 2026

Electromed, Inc. (ELMD) Hits Fresh High: Is There Still Room to Run?
Electromed (ELMD) is at a 52-week high, but can investors hope for more gains in the future? We take a look at the company's fundamentals for clues.
Zacks Investment Research • Jun 1, 2026

3 Medical Instrument Stocks Exploring GenAI to Tackle Industry Woes
GenAI is reshaping medical instruments as Electromed, Globus Medical and Intuitive Surgical navigate M&A and market pressures.
Zacks Investment Research • May 21, 2026

Electromed, Inc. (ELMD)'s Technical Outlook is Bright After Key Golden Cross
Electromed, Inc. (ELMD) reached a significant support level, and could be a good pick for investors from a technical perspective. Recently, ELMD's 50-day simple moving average broke out above its 200-day moving average; this is known as a "golden cross.
Zacks Investment Research • May 19, 2026

Electromed (ELMD) is an Incredible Growth Stock: 3 Reasons Why
Electromed (ELMD) possesses solid growth attributes, which could help it handily outperform the market.
Zacks Investment Research • May 18, 2026

What Makes Electromed (ELMD) a Good Fit for 'Trend Investing'
Electromed (ELMD) could be a great choice for investors looking to make a profit from fundamentally strong stocks that are currently on the move. It is one of the several stocks that made it through our "Recent Price Strength" screen.
Zacks Investment Research • May 15, 2026

5 High-Efficiency Stocks to Buy Now: HCSG, ELMD, UMBF, SHEL, MTSI
HCSG, ELMD, UMBF, SHEL and MTSI passed an efficiency screen based on turnover ratios, asset use and operating margin strength.
Zacks Investment Research • May 15, 2026

All You Need to Know About Electromed (ELMD) Rating Upgrade to Strong Buy
Electromed (ELMD) has been upgraded to a Zacks Rank #1 (Strong Buy), reflecting growing optimism about the company's earnings prospects. This might drive the stock higher in the near term.
Zacks Investment Research • May 14, 2026

¹ Disclosures

Open an M1 investment account to buy and sell Electromed Inc. commission-free¹. Build wealth for the long term using automated trading and transfers.